Association Between the Early Discontinuation of Durvalumab and Poor Survival in Patients With Stage III NSCLC

by Narek Shaverdian, MD, Michael Offin, MD, Annemarie F. Shepherd, MD, Matthew D. Hellmann, MD, Daniel R. Gomez, MD, Jamie E. Chaft, MD, Andreas Rimner, MD
Published 2021-07-01

Radiation pneumonitis in lung cancer patients treated with chemoradiation plus durvalumab

by Narek Shaverdian, Maria Thor, Annemarie F. Shepherd, Michael D. Offin, Andrew Jackson, Abraham J. Wu, Daphna Y. Gelblum, Ellen D. Yorke, Charles B. Simone II, Jamie E. Chaft, Matthew D. Hellmann, Daniel R. Gomez, Andreas Rimner, Joseph O. Deasy
Published 2020-07-01

Increasing Heart Dose Reduces Overall Survival in Patients Undergoing Postoperative Radiation Therapy for NSCLC

by Annemarie F. Shepherd, MD, Anthony F. Yu, MD, Michelle Iocolano, MD, Jonathan E. Leeman, MD, Aaron T. Wild, MD, Brandon S. Imber, MD, MA, Jamie E. Chaft, MD, Michael Offin, MD, James Huang, MD, James M. Isbell, MD, MSCI, Abraham J. Wu, MD, Daphna Y. Gelblum, MD, Narek Shaverdian, MD, Charles B. Simone, II, MD, Daniel Gomez, MD, Ellen Yorke, PhD, Andrew Jackson, PhD, Andreas Rimner, MD
Published 2021-08-01